[CRVS] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
30-Jul-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 17.97%
YoY- 18.24%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,580 27,347 -9,796 -10,611 -12,935 -11,047 -11,004 3.45%
Tax -3 -143 0 0 0 -185 -186 -93.60%
NP -11,580 27,347 -9,796 -10,611 -12,935 -11,047 -11,004 3.45%
Tax Rate - 0.52% - - - - - -
Total Cost 11,580 -27,347 9,796 10,611 12,935 11,047 11,004 3.45%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -0.34 0.92 -0.33 -0.36 -0.44 -0.38 -0.37 -5.47%
EPS Diluted -0.34 0.92 -0.33 -0.36 -0.44 -0.38 -0.37 -5.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.